BioLegend develops and manufactures world-class, cutting-edge antibodies and reagents for biomedical research, offered at an outstanding value. Our product areas include cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., who was also the co-founder of PharMingen.
Specialties
Antibodies, Flow Cytometry, Immunoassay kits, ELISA kits
BioLegend Activity on LinkedIn
-
BioLegend has a new Purchasing Agent
Ardez Coching is now Purchasing Agent, was Buyer & Manufacturing Administrator at BeneChill Inc

